Browse studies

Find your next paid study

27,384 recruiting studies available now

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

This is a single arm, open-label phase II study to assess the efficacy of single agent pembrolizumab for the treatment of advanced cutaneous sarcomas. Adult pa…

Cutaneous Sarcoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

H. Lee Moffitt Cancer Center and Research InstituteNCT07007273

Natural History Investigation Into Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism

Background: Smith-Lemli-Opitz Syndrome (SLOS) is a genetic disorder. It can cause birth defects and developmental delays. There is no cure for SLOS or other i…

Smith Lemli Opitz SyndromeCHILD SyndromeLathosterolosis+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT05047354

Observational

Guided Physical Activity Counseling: A Pilot Study

This 1-arm pilot study will test the feasibility of recruitment and use of the Physical Activity Counseling Tool (PACT) in 40 UC San Diego Health patients.

Physical ActivityFitness TrackerBehavioral Intervention+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT07869784

Phase 3

A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant

The goal of this Phase 3 clinical trial is to compare ARINA-1 (a nebulized immunomodulatory agent) plus Standard of Care vs Standard of Care alone. The main qu…

Pre-Bronchiolitis Obliterans Syndrome

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Renovion, Inc.NCT05654922

Phase 3

Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder: A Randomized Controlled Trial (NOVASTIM)

The goal of this clinical trial is to study the NiNA System and how it works to treat overactive bladder. Up to 290 participants will be enrolled in the study …

Overactive Bladder (OAB)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

NinaMED Pty LtdNCT07780786

Phase 1

A Phase Ib/II Study of the Mirdametinib in Combination With Palbociclib in Patients With Advanced Dedifferentiated Liposarcoma

The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, re…

Well Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT06843967

Observational

Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment

The goal of this one-arm clinical trial is to determine whether participants with mild cognitive impairment (MCI) can successfully navigate a virtual reality (…

Mild Cognitive Impairment (MCI)

Estimated

~$10 – $750

Actual pay is set by the research site.

Albert Einstein College of MedicineNCT07225400

Phase 2

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of excessive dayt…

Narcolepsy

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Eisai Inc.NCT07493265

Phase 4

Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress

Post-traumatic stress disorder (PTSD) is a common consequence of combat that can result in trauma-related hyperarousal and sleep disturbances. Poor sleep, one …

Sleep Initiation and Maintenance DisordersStress Disorders, Posttraumatic

Estimated

~$25 – $900

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT03642028

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have Metabolic dysfuncti…

Metabolic Dysfunction-Associated SteatoHepatitis (MASH)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT05519475

Phase 2

Feasibility, Acceptability, and Preliminary Efficacy of Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: An Open-Label Pilot Study

This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with stro…

Alcohol Use Disorder (AUD)HIV

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Yale UniversityNCT07040592

Phase 2

PREDICT-RD: Postoperative Molecular Residual Disease by ctDNA Surveillance in TNBC With Residual Disease

This is a Phase II, interventional, prospective, single-arm, multi-center study that will enroll patients with stage II/III triple negative breast cancer (TNBC…

Breast CancerResidual DiseaseTriple Negative Breast Cancer (TNBC)+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT07069595